Vas Narasimhan

Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton

by | May 12, 2026
When completed in 2028, the company’s first Texas‑based manufacturing facility will bring RLT medications closer to patients across the southern United States, becoming the fifth RLT site nationwide, Novartis said.
MORE
Global Pharma Giant Novartis To Build Next-Gen Cancer Drug Plant in Denton, Creating North Texas Jobs
by | Feb 25, 2026
The purpose-built radiopharmaceutical site is the company’s fifth in the U.S. and the first manufacturing facility in Texas. It's expected to create new jobs in bioengineering, advanced manufacturing, quality, and operations.
MORE